PMID- 36963867 OWN - NLM STAT- MEDLINE DCOM- 20230328 LR - 20230422 IS - 2405-4577 (Electronic) IS - 2405-4577 (Linking) VI - 54 DP - 2023 Apr TI - N-acetylecysteine, a powerful agent in the reinforcement of anti-oxidant profile: A systematic review and dose-response meta-analysis of controlled clinical trials. PG - 227-238 LID - S2405-4577(23)00023-2 [pii] LID - 10.1016/j.clnesp.2023.01.021 [doi] AB - BACKGROUND AND AIM: Several studies have been conducted to evaluate the effect of N-acetylecysteine (NAC) supplementation on antioxidant status, while no dose-response meta-analysis summarized the efficacy of NAC supplementation. METHODS: The systematic search of literatures was conducted on Scopus, PubMed, Embase, Web of Science electronic databases. Controlled clinical trials investigating the effects of NAC on antioxidant biomarkers were included in the current meta-analysis. Random-effect model was used to perform meta-analysis. Heterogeneity was examined using I(2) index. Subgroup analysis was carried out to find the possible sources of heterogeneity. Dose-response analysis was performed to find the non-linear relationships between effect size and independent variables. RESULTS: Overall, 26 eligible studies were included in the review. NAC supplementation significantly increased TAC (SMD = 0.77 mumol/L; 95% CI: 0.38, 1.16; p < 0.001), GSH (SMD = 0.80 nmol/ml; 95% CI:0.25, 1.34; p = 0.004) and CAT (SMD = -0.57 IU/L; 95% CI:-1.13, -0.02; p = 0.042) levels. However, no significant improving effect was observed in terms of GR (SMD = 0.25 IU/g; 95% CI:-0.14, 0.63; p = 0.210), SOD (SMD = 0.14 U/ml; 95% CI:-0.20, 0.49; p = 0.414) and GPx (SMD = 0.19 IU/g; 95% CI:-0.48, 0.86; p = 0.576) levels. Furthermore, dose-response analysis show that NAC supplementation in participants with mean age up to 30 years had more robust effect on increasing GSH levels. CONCLUSION: We found a significant effect of NAC supplementation on TAC, GSH, CAT in adults. Overall, NAC could be considered as a potent agent in enhancing antioxidant capacity. CI - Copyright (c) 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved. FAU - Mahmoudinezhad, Mahsa AU - Mahmoudinezhad M AD - Nutrition Research Center, Department of Community Nutrition, Student Research Committee, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Abbaszadeh, Fatemeh AU - Abbaszadeh F AD - Nutrition Research Center, Department of Nutrition and Diet Therapy, Student Research Committee, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Zarezadeh, Meysam AU - Zarezadeh M AD - Nutrition Research Center, Department of Clinical Nutrition, Student Research Committee, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: meysam.za93@gmail.com. FAU - Bahreini, Nazgol AU - Bahreini N AD - Nutrition Research Center, Department of Nutrition and Diet Therapy, Student Research Committee, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Jamilian, Parsa AU - Jamilian P AD - Keele Medical School, Keele University, Staffordshire, UK. FAU - Jamilian, Parmida AU - Jamilian P AD - School of Pharmacy and Bio Engineering, Keele University, Staffordshire, UK. FAU - Ostadrahimi, Alireza AU - Ostadrahimi A AD - Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: ostadrahimi@tbzmed.ac.ir. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Systematic Review DEP - 20230124 PL - England TA - Clin Nutr ESPEN JT - Clinical nutrition ESPEN JID - 101654592 RN - 0 (Antioxidants) RN - 0 (Biomarkers) SB - IM MH - *Antioxidants/pharmacology MH - *Dietary Supplements MH - Oxidative Stress MH - Biomarkers/metabolism OTO - NOTNLM OT - Anti-oxidant OT - Meta-analysis OT - N-acetylecysteine OT - Oxidative stress OT - Systematic review COIS- Declaration of competing interest None. EDAT- 2023/03/25 06:00 MHDA- 2023/03/28 17:16 CRDT- 2023/03/24 21:55 PHST- 2022/07/12 00:00 [received] PHST- 2022/12/18 00:00 [revised] PHST- 2023/01/17 00:00 [accepted] PHST- 2023/03/28 17:16 [medline] PHST- 2023/03/24 21:55 [entrez] PHST- 2023/03/25 06:00 [pubmed] AID - S2405-4577(23)00023-2 [pii] AID - 10.1016/j.clnesp.2023.01.021 [doi] PST - ppublish SO - Clin Nutr ESPEN. 2023 Apr;54:227-238. doi: 10.1016/j.clnesp.2023.01.021. Epub 2023 Jan 24.